Literature DB >> 7929517

Evaluation of Graftskin composite grafts on full-thickness wounds on athymic mice.

J F Hansbrough1, J Morgan, G Greenleaf, M Parikh, C Nolte, L Wilkins.   

Abstract

We used a living bilayered cultured skin replacement to close full-thickness wound defects on the dorsum of athymic mice. The skin replacement is composed of human fibroblasts that condense a bovine collagen lattice; the lattice is then seeded with cultured human keratinocytes. The collagen lattice with fibroblasts serves as a dermal template, and the overlying human keratinocytes form the epidermal component of this composite skin replacement. Twenty-four animals were grafted, and groups of six were killed and biopsied at 6, 15, 30, and 60 days after graft replacement. Twenty-four mice in the control group receiving grafts of fresh, split-thickness, human cadaver skin were biopsied at the same time points. "Take" of all grafts was excellent, with only one graft loss in the 48 mice (one Graftskin graft, at 15 days). Light microscopy revealed that vascular ingrowth into Graftskin occurred rapidly, and discrete dermal and epidermal layers were seen at all time points. Evidence of basement membrane formation was seen at 6 days after grafting by immunohistochemical staining for laminin and by electron microscopic visualization of lamina lucida and lamina densa zones at the dermal-epidermal junction. The results demonstrated that Graftskin formed a structurally complete skin replacement within 1 week of placement on full-thickness wounds on athymic mice, and effective skin coverage was provided for the 60-day observation period after grafting.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929517     DOI: 10.1097/00004630-199407000-00010

Source DB:  PubMed          Journal:  J Burn Care Rehabil        ISSN: 0273-8481


  8 in total

1.  Synthesis of organs: in vitro or in vivo?

Authors:  I V Yannas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

2.  Bioactive glass scaffolds for bone tissue engineering: state of the art and future perspectives.

Authors:  Qiang Fu; Eduardo Saiz; Mohamed N Rahaman; Antoni P Tomsia
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2011-10-10       Impact factor: 7.328

Review 3.  Cultivation of human keratinocyte stem cells: current and future clinical applications.

Authors:  G Pellegrini; S Bondanza; L Guerra; M De Luca
Journal:  Med Biol Eng Comput       Date:  1998-11       Impact factor: 2.602

Review 4.  Tissue-engineered human skin substitutes developed from collagen-populated hydrated gels: clinical and fundamental applications.

Authors:  F A Auger; M Rouabhia; F Goulet; F Berthod; V Moulin; L Germain
Journal:  Med Biol Eng Comput       Date:  1998-11       Impact factor: 2.602

Review 5.  Bioactive glass in tissue engineering.

Authors:  Mohamed N Rahaman; Delbert E Day; B Sonny Bal; Qiang Fu; Steven B Jung; Lynda F Bonewald; Antoni P Tomsia
Journal:  Acta Biomater       Date:  2011-03-21       Impact factor: 8.947

Review 6.  Stem cell therapy for critical limb ischemia: what can we learn from cell therapy for chronic wounds?

Authors:  Caroline Jadlowiec; Robert A Brenes; Xin Li; Wei Lv; Clinton D Protack; Michael J Collins; Alan Dardik
Journal:  Vascular       Date:  2012-10-19       Impact factor: 1.285

7.  Bioactive glass-collagen/poly (glycolic acid) scaffold nanoparticles exhibit improved biological properties and enhance osteogenic lineage differentiation of mesenchymal stem cells.

Authors:  Shirin Toosi; Hojjat Naderi-Meshkin; Zohreh Esmailzadeh; Ghazal Behravan; Seeram Ramakrishna; Javad Behravan
Journal:  Front Bioeng Biotechnol       Date:  2022-09-07

Review 8.  Tissue engineering in burn scar reconstruction.

Authors:  Ppm van Zuijlen; Klm Gardien; Meh Jaspers; E J Bos; D C Baas; Ajm van Trier; E Middelkoop
Journal:  Burns Trauma       Date:  2015-09-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.